• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Perimeter Solutions Reports First Quarter 2026 Financial Results

    5/6/26 6:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials
    Get the next $PRM alert in real time by email

    First quarter Net Income of $72.9M and Adjusted Net Income of $9.0M

    Continued value driver execution and recent acquisitions drove first quarter Adjusted EBITDA of $41.2M

    First quarter Earnings Per Diluted Share of $0.44 and Adjusted Earnings Per Diluted Share of $0.06

    Entered into key five-year contracts with the United States Defense Logistics Agency for suppressants and with California Department of Forestry for retardants in April 2026

    CLAYTON, Mo., May 06, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, today reported financial results for its first quarter ended March 31, 2026.

    First Quarter 2026 Results

    • Net sales increased 74% to $125.1 million in the first quarter, as compared to $72.0 million in the prior year quarter.



      • Fire Safety net sales increased 22% to $45.5 million, as compared to $37.1 million in the prior year quarter.
      • Specialty Products net sales increased 128% to $79.6 million, as compared to $34.9 million in the prior year quarter.
    • Net income during the first quarter was $72.9 million, or $0.44 earnings per diluted share, as compared to net income of $56.7 million, or $0.36 earnings per diluted share in the prior year quarter.
    • First quarter non-GAAP adjusted earnings per diluted share was $0.06, as compared to non-GAAP adjusted earnings per diluted share of $0.03 in the prior year quarter.
    • Adjusted EBITDA increased 128% to $41.2 million in the first quarter, as compared to $18.1 million in the prior year quarter.



      • Fire Safety Segment Adjusted EBITDA increased 85% to $18.7 million, as compared to $10.1 million in the prior year quarter.
      • Specialty Products Segment Adjusted EBITDA increased 181% to $22.5 million, as compared to $8.0 million in the prior year quarter.
    • Reconciliation tables for non-GAAP measures are available in the attached schedules.

    Capital Allocation

    • On January 22, 2026, the Company acquired the outstanding capital stock of Medical Manufacturing Technologies, LLC ("MMT") for a total cash purchase price, net of cash acquired of $682.3 million which was funded with cash on hand and proceeds from a senior secured notes offering. MMT is included within the Specialty Products segment.
    • The Company invested $5.8 million in capital expenditures during the quarter ended March 31, 2026.



    Conference Call and Webcast

    As previously announced, Perimeter Solutions management will hold a conference call at 8:30 a.m. ET on Wednesday, May 6, 2026 to discuss financial results for the first quarter 2026. The conference call can be accessed by dialing (877) 407-9764 (toll-free) or (201) 689-8551 (toll).

    The conference call will also be webcast simultaneously on Perimeter's website (https://ir.perimeter-solutions.com), accessed under the Investor Relations page. The webcast link will be made available on the Company's website prior to the start of the call; go to the investor relations page of our website to the News & Events menu and click on "Events & Presentations."

    A slide presentation will also be available for reference during the conference call; go to the investor relations page of our website to the News & Events menu and click on "Events & Presentations."

    Following the live webcast, a replay will be available on the Company's website. A telephonic replay will also be available approximately three hours after the call and can be accessed by dialing (877) 660-6853 (toll-free) or (201) 612-7415 (toll) and using Access ID "13758345". The telephonic replay will be available until June 6, 2026 (11:59 p.m. ET).

    About Perimeter Solutions

    Perimeter Solutions (NYSE:PRM) is a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications. Perimeter's focus on superior customer service, paired with our Value Driver-focused operating strategy, decentralized operating model, and focus on driving value via capital allocation and capital structure management, fulfills our dual mandate: to serve customers and create value for stockholders. Perimeter is comprised of two segments, Fire Safety, including fire retardants and fire suppressants, and Specialty Products, which currently spans lubricant additives, electronic and electro-mechanical components, and highly engineered machinery for the medical device industry. Perimeter expects to continue expanding its portfolio through organic growth and value creating acquisitions.

    Forward-looking Information

    This press release may contain "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will," and similar references to future periods.

    Any such forward-looking statements are not guarantees of performance or results, and involve risks, uncertainties (some of which are beyond the Company's control) and assumptions. Although Perimeter believes any forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect the Company's actual financial results and cause them to differ materially from those anticipated in any forward-looking statements, including the risk factors described from time to time by us in our filings with the Securities and Exchange Commission ("SEC"), including, but not limited to, the Company's Annual Report on Form 10-K for the year ended December 31, 2025. Stockholders, potential investors and other readers should consider these factors carefully in evaluating the forward-looking statements.

    Any forward-looking statement made by Perimeter in this press release speaks only as of the date on which it is made. Perimeter undertakes no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

    SOURCE: Perimeter Solutions, Inc.

    CONTACT: ir@perimeter-solutions.com

    PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES

    Condensed Consolidated Statements of Operations and Comprehensive Income

    (in thousands, except share and per share data)

    (Unaudited)
      
     Three Months Ended March 31,
      2026   2025 
    Net sales$125,069  $72,030 
    Cost of goods sold 74,282   43,877 
    Gross profit 50,787   28,153 
    Operating expenses (income):   
    Selling, general and administrative expense 23,061   16,299 
    Amortization expense 22,599   14,099 
    Founders advisory fees - related party (76,378)  (80,613)
    Other operating expense 9,018   561 
    Total operating income (21,700)  (49,654)
    Operating income 72,487   77,807 
    Other expense (income):   
    Interest expense, net 24,356   9,644 
    Foreign currency gain (1,351)  (1,159)
    Other (income) expense, net (364)  143 
    Total other expense, net 22,641   8,628 
    Income before income taxes 49,846   69,179 
    Income tax benefit (expense) 23,090   (12,493)
    Net income 72,936   56,686 
    Other comprehensive (loss) income, net of tax:   
    Foreign currency translation adjustments (6,566)  7,885 
    Total comprehensive income$66,370  $64,571 
    Earnings per share:   
    Basic$0.47  $0.38 
    Diluted$0.44  $0.36 
    Weighted average number of shares outstanding:   
    Basic 153,863,650   148,556,284 
    Diluted 165,074,373   156,727,696 



    PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES

    Condensed Consolidated Balance Sheets

    (in thousands, except share data)
        
     March 31, 2026 December 31, 2025
    ASSETS(Unaudited)  
    Current assets:   
    Cash and cash equivalents$91,624  $325,927 
    Accounts receivable, net 87,536   64,363 
    Inventories 191,026   139,634 
    Prepaid expenses and other current assets 27,987   34,049 
    Total current assets 398,173   563,973 
    Property, plant and equipment, net 101,296   85,138 
    Operating lease right-of-use assets 37,297   30,152 
    Finance lease right-of-use assets 5,490   5,713 
    Goodwill 1,365,415   1,065,211 
    Customer lists, net 924,377   628,189 
    Technology and patents, net 200,318   184,804 
    Tradenames, net 125,297   86,330 
    Other assets, net 6,715   3,497 
    Total assets$3,164,378  $2,653,007 
    LIABILITIES AND STOCKHOLDERS' EQUITY   
    Current liabilities:   
    Accounts payable$38,408  $30,301 
    Accrued expenses and other current liabilities 61,322   47,212 
    Founders advisory fees payable - related party 25,839   95,726 
    Deferred revenue 3,322   1,879 
    Total current liabilities 128,891   175,118 
    Long-term debt, net 1,209,650   669,122 
    Operating lease liabilities, net of current portion 32,858   27,860 
    Finance lease liabilities, net of current portion 5,560   5,694 
    Deferred income taxes 121,788   80,410 
    Founders advisory fees payable - related party 338,480   440,697 
    Preferred stock 117,753   115,904 
    Preferred stock - related party 586   1,293 
    Other non-current liabilities 3,963   3,590 
    Total liabilities 1,959,529   1,519,688 
    Commitments and contingencies   
    Stockholders' equity:   
    Common stock, $0.0001 par value per share, 4,000,000,000 shares authorized; 188,505,219 and 174,818,216 shares issued; 163,127,063 and 149,440,060 shares outstanding at March 31, 2026 and December 31, 2025, respectively 19   17 
    Treasury stock, at cost; 25,378,156 shares at March 31, 2026 and December 31, 2025 (168,197)  (168,197)
    Additional paid-in capital 2,106,116   2,100,958 
    Accumulated other comprehensive loss (12,936)  (6,370)
    Accumulated deficit (720,153)  (793,089)
    Total stockholders' equity 1,204,849   1,133,319 
    Total liabilities and stockholders' equity$3,164,378  $2,653,007 



    PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES

    Condensed Consolidated Statements of Cash Flows

    (in thousands)

    (Unaudited)
      
     Three Months Ended March 31,
      2026   2025 
    Cash flows from operating activities:   
    Net income$72,936  $56,686 
    Adjustments to reconcile net income to net cash (used in) provided by operating activities:   
    Founders advisory fees - related party (change in fair value) (76,378)  (80,613)
    Depreciation and amortization expense 27,139   16,893 
    Interest and payment-in-kind on preferred stock 1,904   1,833 
    Stock-based compensation 2,598   2,671 
    Non-cash lease expense 2,513   1,395 
    Deferred income taxes (27,055)  8,927 
    Amortization of deferred financing costs 709   444 
    Foreign currency gain (1,351)  (1,159)
    Loss on disposal of assets 17   3 
    Changes in operating assets and liabilities, net of acquisitions:   
    Accounts receivable 3,424   11,830 
    Inventories (3,099)  2,145 
    Prepaid expenses and current other assets 878   766 
    Accounts payable (976)  (3,513)
    Deferred revenue 219   4,564 
    Income taxes payable, net 5,338   1,660 
    Accrued expenses and other current liabilities 2,399   7,253 
    Founders advisory fees - related party (cash settled) (95,726)  (6,677)
    Operating lease liabilities (1,903)  (994)
    Finance lease liabilities (119)  (127)
    Other, net (2,428)  (241)
    Net cash (used in) provided by operating activities (88,961)  23,746 
    Cash flows from investing activities:   
    Purchase of property and equipment (5,801)  (4,813)
    Purchase of businesses, net of cash acquired (682,294)  (10,000)
    Net cash used in investing activities (688,095)  (14,813)
    Cash flows from financing activities:   
    Common stock repurchased —   (8,183)
    Proceeds from exercises of options 3,000   41 
    Principal payments on finance lease obligations (179)  (251)
    Proceeds from issuance of long-term debt 550,000   — 
    Payment of debt issuance costs (10,057)  — 
    Net cash provided by (used in) financing activities 542,764   (8,393)
    Effect of foreign currency on cash and cash equivalents (11)  1,054 
    Net change in cash and cash equivalents (234,303)  1,594 
    Cash and cash equivalents, beginning of period 325,927   198,456 
    Cash and cash equivalents, end of period$91,624  $200,050 
    Supplemental disclosures of cash flow information:   
    Cash paid for interest$154  $6 
    Cash (received) paid for income taxes$(2,034) $530 
            

    Non-GAAP Financial Metrics

    The Company provides non-GAAP financial measures for Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted Net Income, and Adjusted Earnings Per Share data as supplemental information regarding the Company's business performance. The Company believes that these non-GAAP financial measures are useful to investors because they provide investors with a better understanding of the Company's past financial performance and future results. The Company's management uses these non-GAAP financial measures when it internally evaluates the performance of its business and makes operating decisions, including internal operating budgeting, performance measurement, and discretionary compensation.

    Adjusted EBITDA and Segment Adjusted EBITDA

    Adjusted EBITDA and Segment Adjusted EBITDA are defined as income (loss) before income taxes plus net interest and other financing expenses, and depreciation and amortization, adjusted on a consistent basis for certain non-recurring, unusual or non-operational items. These items include (i) restructuring, (ii) acquisition related costs, (iii) founder advisory fee expenses, (iv) stock-based compensation expense, (v) purchase accounting impact and (vi) foreign currency loss (gain). To supplement the Company's condensed consolidated financial statements presented in accordance with U.S. GAAP, Perimeter is providing a summary to show the computations of Adjusted EBITDA and Segment Adjusted EBITDA, which are non-GAAP measures used by the Company's management and by external users of Perimeter's financial statements, such as debt and equity investors, commercial banks and others, to assess the Company's operating performance as compared to that of other companies, without regard to financing methods, capital structure or historical cost basis. Adjusted EBITDA and Segment Adjusted EBITDA should not be considered an alternative to net income (loss), operating income (loss), cash flows provided by (used in) operating activities or any other measure of financial performance or liquidity presented in accordance with U.S. GAAP (in thousands).

    (Unaudited)Three Months Ended March 31, 2026 Three Months Ended March 31, 2025
     Fire Safety Specialty

    Products
     Total Fire Safety Specialty

    Products
     Total
    Income (loss) before income taxes$62,127  $(12,281) $49,846  $58,878  $10,301  $69,179 
    Depreciation and amortization 14,492   12,647   27,139   12,765   4,128   16,893 
    Interest and financing expense 10,455   13,901   24,356   5,954   3,690   9,644 
    Founders advisory fees - related party (66,890)  (9,488)  (76,378)  (69,327)  (11,286)  (80,613)
    Non-recurring expenses(1) 132   259   391   234   673   907 
    Acquisition costs 10   8,958   8,968   —   561   561 
    Stock-based compensation expense 716   1,882   2,598   1,576   1,095   2,671 
    Purchase accounting impact(2) —   5,590   5,590   —   —   — 
    Foreign currency (gain) loss (2,351)  1,000   (1,351)  5   (1,164)  (1,159)
    Segment Adjusted EBITDA$18,691  $22,468  $41,159  $10,085  $7,998  $18,083 



    (1) For the three months ended March 31, 2026, $0.3 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company, and $0.1 million was related to restructuring and other non-recurring costs. For the three months ended March 31, 2025, $0.5 million was related to restructuring and other non-recurring costs, and $0.4 million was related to the Redomiciliation Transaction.



    (2) For the three months ended March 31, 2026, $5.6 million was primarily related to the impact of purchase accounting on the cost of inventory sold. The inventory acquired received a purchase accounting step-up in basis.
       

    Adjusted Net Income and Adjusted Earnings Per Share

    The computation of Adjusted Earnings Per Share ("Adjusted EPS") is defined as Adjusted Net Income divided by adjusted diluted shares. Adjusted Net Income is defined as net income (loss) plus amortization, certain non-recurring, unusual or non-operational items, and the tax impact of these non-GAAP adjustments. These adjustments include (i) restructuring, (ii) acquisition related costs, (iii) founder advisory fee expenses, (iv) stock-based compensation expense, (v) purchase accounting impact and (vi) foreign currency loss (gain). Adjusted diluted shares is the weighted average diluted shares outstanding, adjusted by adding dilution for options excluded under U.S. GAAP due to a net loss, less dilution related to founders advisory fees. To supplement the Company's condensed consolidated financial statements presented in accordance with U.S. GAAP, Perimeter is providing a summary to show the computations of Adjusted Net Income and Adjusted EPS, which are non-GAAP measures used by the Company's management and by external users of Perimeter's financial statements, such as debt and equity investors, commercial banks and others, to assess the Company's operating performance as compared to that of other companies, without regard to financing methods, capital structure or historical cost basis. Adjusted EPS and Adjusted Net Income should not be considered alternatives to GAAP earnings (loss) per share ("GAAP EPS"), net income (loss), operating income (loss), cash flows provided by (used in) operating activities or any other measure of financial performance or liquidity presented in accordance with U.S. GAAP (in thousands, except share and per share data).

    (Unaudited)Three Months Ended March 31,
        2026   2025 
    GAAP net income$72,936  $56,686 
    Adjustments:   
    Amortization 22,599   14,099 
    Founders advisory fees - related party (76,378)  (80,613)
    Non-recurring expenses(1) 391   907 
    Acquisition costs 8,968   561 
    Stock-based compensation expense 2,598   2,671 
    Purchase accounting impact(2) 5,590   — 
    Foreign currency gain (1,351)  (1,159)
    Tax impact of non-GAAP adjustments(3) (26,319)  10,937 
    Adjusted net income$9,034  $4,089 
          
    Shares used in computing GAAP Earnings Per Share (diluted) 165,074,373   156,727,696 
    Options(4) —   — 
    Shares underlying Founders fixed advisory fees(5) (4,714,122)  (7,071,183)
    Shares underlying Founders variable advisory fees(6) —   — 
    Shares used in computing Adjusted Earnings Per Share (diluted) 160,360,251   149,656,513 
          
    GAAP Earnings Per Share (diluted)$0.44  $0.36 
    Adjusted Earnings Per Share (diluted)$0.06  $0.03 
    ____________________   
          
    (1)

     For the three months ended March 31, 2026, $0.3 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company, and $0.1 million was related to restructuring and other non-recurring costs. For the three months ended March 31, 2025, $0.5 million was related to restructuring and other non-recurring costs, and $0.4 million was related to the Redomiciliation Transaction.

    (2)

     For the three months ended March 31, 2026, $5.6 million was primarily related to the impact of purchase accounting on the cost of inventory sold. The inventory acquired received a purchase accounting step-up in basis.

    (3)

     The tax impact of non-GAAP adjustments reflects the total income tax expense commensurate with the non-GAAP measure of profitability.

    (4)

     The Company adds back the dilutive impact of options if amounts were excluded for purposes of GAAP EPS due to a GAAP net loss during the period.

    (5)

     As of March 31, 2026, a maximum of 2.4 million shares were issuable within 12 months under the Founders fixed advisory fee.

    (6)

     Based on period end market prices as of March 31, 2026, no shares were issuable within 12 months under the Founders variable advisory fee.





    Primary Logo

    Get the next $PRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PRM

    DatePrice TargetRatingAnalyst
    7/9/2026$50.00Overweight
    Analyst
    6/9/2026$48.00Market Outperform
    CJS Securities
    3/31/2026$30.00Neutral → Buy
    UBS
    1/12/2026$31.00Buy → Neutral
    UBS
    3/26/2025$14.00Neutral → Buy
    UBS
    10/11/2023$7.00 → $4.25Buy → Neutral
    UBS
    6/9/2022$14.00Overweight
    Morgan Stanley
    4/14/2022$15.00Buy
    UBS
    More analyst ratings

    $PRM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Large owner Windacre Partnership Llc sold $195,609,062 worth of Ordinary shares (5,705,979 units at $34.28) (SEC Form 4)

    4/A - Perimeter Solutions, Inc. (0001880319) (Issuer)

    7/13/26 5:30:32 PM ET
    $PRM
    Major Chemicals
    Industrials

    Large owner Windacre Partnership Llc sold $195,609,062 worth of Ordinary shares (5,705,979 units at $34.28) (SEC Form 4)

    4 - Perimeter Solutions, Inc. (0001880319) (Issuer)

    6/30/26 7:51:15 PM ET
    $PRM
    Major Chemicals
    Industrials

    Chief Executive Officer Khouri Haitham sold $7,284,108 worth of shares (229,535 units at $31.73), decreasing direct ownership by 11% to 1,874,615 units (SEC Form 4)

    4 - Perimeter Solutions, Inc. (0001880319) (Issuer)

    5/22/26 5:39:28 PM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    SEC Filings

    View All

    SEC Form 144 filed by Perimeter Solutions SA

    144 - Perimeter Solutions, Inc. (0001880319) (Subject)

    6/12/26 5:21:50 PM ET
    $PRM
    Major Chemicals
    Industrials

    SEC Form 144 filed by Perimeter Solutions SA

    144 - Perimeter Solutions, Inc. (0001880319) (Subject)

    6/12/26 5:21:33 PM ET
    $PRM
    Major Chemicals
    Industrials

    Perimeter Solutions SA filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Perimeter Solutions, Inc. (0001880319) (Filer)

    5/28/26 1:37:39 PM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Windacre Partnership Master Fund, Lp bought $3,559,308 worth of Ordinary shares (254,600 units at $13.98) (SEC Form 4)

    4 - Perimeter Solutions, Inc. (0001880319) (Issuer)

    7/1/25 5:30:36 PM ET
    $PRM
    Major Chemicals
    Industrials

    Director Valladares Jorge bought $300,258 worth of Ordinary Shares (42,000 units at $7.15) (SEC Form 4)

    4 - Perimeter Solutions, SA (0001880319) (Issuer)

    6/13/24 5:06:34 PM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries

    Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman KKR today announced the launch of Allyntra ("Allyntra" or the "Company"), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion. This press release feature

    7/9/26 6:59:00 AM ET
    $KKR
    $PRM
    Investment Managers
    Finance
    Major Chemicals
    Industrials

    Medical Manufacturing Technologies (MMT) Appoints Grant Bowman as President to Lead the Company's Next Chapter of Growth and Innovation

    Medical Manufacturing Technologies (MMT), a Perimeter Solutions company and a leading provider of precision manufacturing technologies for the medical device and advanced industrial markets, today announced the appointment of Grant Bowman as President. Bowman will guide the company's next phase of growth while continuing MMT's customer-first approach and long-standing tradition of solving complex manufacturing challenges. As MMT enters this new phase of leadership, customers can expect the same experienced teams and responsive support across the company's Catheter, Guidewire, Abrasive, and Automation Technologies, and the company’s broader portfolio of solutions. This press release feature

    6/25/26 8:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    Perimeter Solutions Reports First Quarter 2026 Financial Results

    First quarter Net Income of $72.9M and Adjusted Net Income of $9.0M Continued value driver execution and recent acquisitions drove first quarter Adjusted EBITDA of $41.2M First quarter Earnings Per Diluted Share of $0.44 and Adjusted Earnings Per Diluted Share of $0.06 Entered into key five-year contracts with the United States Defense Logistics Agency for suppressants and with California Department of Forestry for retardants in April 2026 CLAYTON, Mo., May 06, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missio

    5/6/26 6:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Leadership Updates

    Live Leadership Updates

    View All

    KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries

    Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman KKR today announced the launch of Allyntra ("Allyntra" or the "Company"), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion. This press release feature

    7/9/26 6:59:00 AM ET
    $KKR
    $PRM
    Investment Managers
    Finance
    Major Chemicals
    Industrials

    Medical Manufacturing Technologies (MMT) Appoints Grant Bowman as President to Lead the Company's Next Chapter of Growth and Innovation

    Medical Manufacturing Technologies (MMT), a Perimeter Solutions company and a leading provider of precision manufacturing technologies for the medical device and advanced industrial markets, today announced the appointment of Grant Bowman as President. Bowman will guide the company's next phase of growth while continuing MMT's customer-first approach and long-standing tradition of solving complex manufacturing challenges. As MMT enters this new phase of leadership, customers can expect the same experienced teams and responsive support across the company's Catheter, Guidewire, Abrasive, and Automation Technologies, and the company’s broader portfolio of solutions. This press release feature

    6/25/26 8:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Financials

    Live finance-specific insights

    View All

    Perimeter Solutions Reports First Quarter 2026 Financial Results

    First quarter Net Income of $72.9M and Adjusted Net Income of $9.0M Continued value driver execution and recent acquisitions drove first quarter Adjusted EBITDA of $41.2M First quarter Earnings Per Diluted Share of $0.44 and Adjusted Earnings Per Diluted Share of $0.06 Entered into key five-year contracts with the United States Defense Logistics Agency for suppressants and with California Department of Forestry for retardants in April 2026 CLAYTON, Mo., May 06, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missio

    5/6/26 6:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    Perimeter Announces Date for First Quarter 2026 Earnings Call

    CLAYTON, Mo., April 21, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions (NYSE: PRM) ("Perimeter" or the "Company"), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, announced today it will release its financial results for the first quarter 2026 on Wednesday, May 6, 2026, before the market opens. The Company will host a conference call to discuss these results at 8:30 a.m. ET on the same day. The presentation will be led by CEO Haitham Khouri, CFO Kyle Sable, and Head of Investor Relations Seth Barker. The live webcast of the call can be accessed through Perimeter's investor relations website at 

    4/21/26 4:05:00 PM ET
    $PRM
    Major Chemicals
    Industrials

    Perimeter Solutions Reports Fourth Quarter 2025 Financial Results

    Full year Net Loss of $206.4M and Adjusted Net Income of $206.7M Continued value driver execution drove full year Adjusted EBITDA of $331.7M Full year Loss Per Diluted Share of $1.37 and Adjusted Earnings Per Diluted Share of $1.34 Specialty Products Segment acquired add-on product lines in Q4 2025, and MMT in Q1 2026 CLAYTON, Mo., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, today reported financial results for its fourth quarter, and full year, ended December 3

    2/26/26 6:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Perimeter Solutions SA

    SC 13G/A - Perimeter Solutions, Inc. (0001880319) (Subject)

    11/22/24 6:42:15 PM ET
    $PRM
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Perimeter Solutions SA

    SC 13G/A - Perimeter Solutions, SA (0001880319) (Subject)

    9/5/24 1:16:57 PM ET
    $PRM
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Perimeter Solutions SA (Amendment)

    SC 13G/A - Perimeter Solutions, SA (0001880319) (Subject)

    2/14/24 4:00:13 PM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst initiated coverage on Perimeter Solutions with a new price target

    Analyst initiated coverage of Perimeter Solutions with a rating of Overweight and set a new price target of $50.00

    7/9/26 9:30:24 AM ET
    $PRM
    Major Chemicals
    Industrials

    CJS Securities initiated coverage on Perimeter Solutions with a new price target

    CJS Securities initiated coverage of Perimeter Solutions with a rating of Market Outperform and set a new price target of $48.00

    6/9/26 9:29:28 AM ET
    $PRM
    Major Chemicals
    Industrials

    Perimeter Solutions upgraded by UBS with a new price target

    UBS upgraded Perimeter Solutions from Neutral to Buy and set a new price target of $30.00

    3/31/26 8:06:53 AM ET
    $PRM
    Major Chemicals
    Industrials